👋 Meeting the Future at Web Summit 2025
While exploring the latest innovations at Web Summit 2025, our team at YOUR R&D had the pleasure of meeting the minds behind Unlock Biology. In a sea of tech startups, they stood out by addressing one of the most pressing “silent” crises in modern medicine: the massive gap between data generation and meaningful analysis.
📉 The Data Explosion vs. The Analysis Gap
The healthcare industry is currently responsible for roughly 30% of all data generated globally. In the world of biotech and pharma, data is growing at an incredible 30% CAGR.
However, there is a problem. This “data explosion” has far outpaced our computational and human capabilities to process it. Currently, the pharma industry generates much more data than it can actually analyze. This leads to what is known as “corporate amnesia,” where past insights are lost in siloed notebooks and scripts. This inefficiency is estimated to cost the industry a staggering $35 billion.
🤖 Meet the Swarm: Unlock Biology’s Solution
Unlock Biology is tackling this by building an industrial-grade agent platform. Instead of relying on manual, weeks-long human coding cycles for every new hypothesis, they utilize a “swarm of agents”.
- Autonomous Analysis: These agents “talk” to diverse data sources—including publications, clinical trials, and multi-omics data – to test scientific hypotheses.
- Knowledge Persistence: The platform learns from past data analyses. It populates a massive knowledge base of best practices rather than starting every project from scratch.
- Human-in-the-loop: While the agents are fully autonomous, they are also fully observable. Humans can monitor the “thinking” process and provide instructions or restarts when necessary.
🧬 Why This Matters for Pharma
By combining Large Language Models (LLMs) with specialized bioinformatics pipelines, Unlock Biology creates a reliable data factory. This isn’t just about speed; it’s about quality control in drug discovery. Their platform identifies new candidate medicines and molecules that are currently hidden within un-analyzed, unstructured data piles.
🤝 Synergy: YOUR R&D
At YOUR R&D, we specialize in helping companies scale their digital infrastructure and software capabilities. We see a powerful synergy here:
- Infrastructure Scaling: As Unlock Biology deploys more agents, YOUR R&D can provide the robust cloud architecture and DevOps support needed to manage these “swarms” at an enterprise level.
- Custom Integrations: Our expertise in software development can help biotech firms integrate Unlock Biology’s “agentic memory” directly into their existing R&D workflows, ensuring no data is ever “forgotten” again.
👥 The Experts Behind the Vision
The team brings together deep experience from both AI and Life Sciences.
- Dmitry Kalupin (CEO): A 3x founder with a background in math and high-frequency trading engineering.
- Viktor Petukhov, PhD (Founding Scientist): An award-winning researcher with over 5,000 citations and experience at Harvard Medical School.
- Vadim Nazarov, PhD cand. (CSO): A 2x founder in the AI/Biotech space.
- Mikita Shchutski (CTO): An expert ML Engineer with experience at IQVIA and Thermo Fisher.
What do you think? Is the future of biotech entirely agentic, or will the “human-in-the-loop” always be the bottleneck? Let’s discuss in the comments!
#AI #Bioinformatics #HealthTech #DrugDiscovery #Innovation #BioTech #YOURRND
